Solidigm, a pioneer in enterprise data storage, today announced the launch of the Luceta TM AI Software Suite, a breakthrough AI vision platform that solves the core challenges plaguing traditional ...
London's mayor and medical officer of health are voicing their support for bringing an inhalation centre to London, joining ...
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Swallowing is a fundamental human function that supports nutrition and communication. Damage to swallowing muscles can reduce quality of life and even lead to aspiration pneumonia or malnutrition.
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center ...
Public health, explained: Sign up to receive Healthbeat’s Global Checkup in your inbox a day early. Hello from Nairobi. Last week was an interesting one for me, as I had the chance to moderate a panel ...
From the rice paddies of South Asia to the wheat fields of northern China, summer monsoon rains sustain the livelihoods of ...
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...
The survey conducted by AAHA and Gallant found 95% of industry professionals think stem cell therapy will become a new spectrum of care standard treatment option within 10 years. The American Animal ...
Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug-drug ...
Both image photodetector arrays and retinas are pixelated sensors that dynamically extract various features from the visual scene—e.g., color, brightness, and contrast—before transmitting electrical ...
Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today announced that David Ramsay has been appointed Interim Chief Financial Officer (CFO), effective March 23, 2026. Mr. Ramsay will oversee ...